Aurinia Pharmaceuticals Inc. (AUPH) Gross margin 2019–2025
Aurinia Pharmaceuticals Inc. (AUPH) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.5%FY2025 · since FY2019: 100.0% → 88.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.5% | +0.5 pp |
| FY2024 | 88.0% | -4.0 pp |
| FY2023 | 91.9% | -3.8 pp |
| FY2022 | 95.8% | -1.8 pp |
| FY2021 | 97.6% | -2.4 pp |
| FY2020 | 100.0% | +0.0 pp |
| FY2019 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice